Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, 22050, Taiwan
NCT Number: NCT03765320
To elucidate whether peritoneal closure and retroperitoneal drainage can benefit clinical outcome of early gynecologic cancer patients who underwent retroperitoneal lymph node dissection.
Looking for future studies?
Notify Me20 year and older
Female
Observational
Banqiao District, New Taipei, 22050, Taiwan
To elucidate whether peritoneal closure and retroperitoneal drainage can benefit clinical outcome of early gynecologic cancer patients who underwent retroperitoneal lymph node dissection by reviewing the medical records of patients who underwent retroperitoneal lymph node dissection for stage I or II gynecological cancer in Far Eastern Memorial Hospital, January 2011~December 2017.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Peritoneal closure after pelvic lymph node dissection for early gynecologic cancer
Retroperitoneal drainage after pelvic lymph node dissection for early gynecologic cancer
Time frame: 10 year
To find independent factors that can predict lymphocele occurrence in patients who underwent laparotomic gynecologic oncologic surgery
Time frame: 10 years
To find independent factors that can predict occurrence of surgical complication in patients who underwent laparotomic gynecologic oncologic surgery
Far Eastern Memorial Hospital
Other
Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecological Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01742975
Breast Cancer, Breast Diseases
Grenoble, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT05398458
Cardiovascular Diseases, Cysts
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT04205864
Cysts, Endometrial Neoplasms
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT03914963
Cysts, Hemic and Lymphatic Diseases
View Trial Details